Comment on: Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
Rajagopalan
Govindarajan
G
Patel
Robin
R
Kaveri
Srini V
SV
David
Chella S
CS
D000818:Animals; D006683:HLA-DQ Antigens / Q000502:physiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007249:Inflammation / Q000188:drug therapy*; D016753:Interleukin-10 / Q000502:physiology; D008213:Lymphocyte Activation; D051379:Mice; D008822:Mice, Transgenic; D012772:Shock, Septic / Q000188:drug therapy* / Q000276:immunology; D013290:Streptococcal Infections / Q000188:drug therapy* / Q000276:immunology; D018089:Superantigens / Q000276:immunology
D006683:HLA-DQ Antigens; C109756:HLA-DQ8 antigen; D016756:Immunoglobulins, Intravenous; D018089:Superantigens; D016753:Interleukin-10